March 22 (Reuters) – Thermo Fisher Scientific Inc sent a letter to Affymetrix Inc shareholders on Tuesday, reiterating its argument that its $1.3 billion agreement to acquire the U.S. gene-testing…
The post Thermo Fisher, Origin Tech vie for Affymetrix shareholder votes appeared first on NASDAQ.